SV2002000418A - Inhibidor del intercambiador de socio-hidrogeno de tipo 1 ref. pc1086aado/bb - Google Patents

Inhibidor del intercambiador de socio-hidrogeno de tipo 1 ref. pc1086aado/bb

Info

Publication number
SV2002000418A
SV2002000418A SV2001000418A SV2001000418A SV2002000418A SV 2002000418 A SV2002000418 A SV 2002000418A SV 2001000418 A SV2001000418 A SV 2001000418A SV 2001000418 A SV2001000418 A SV 2001000418A SV 2002000418 A SV2002000418 A SV 2002000418A
Authority
SV
El Salvador
Prior art keywords
inhibitor
pc1086aado
ref
partner
type
Prior art date
Application number
SV2001000418A
Other languages
English (en)
Inventor
Weichao George Chen
Eric David Cox
Perez Angel Guzman
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SV2002000418A publication Critical patent/SV2002000418A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN INHIBIDOR DE NHE-1, METODOS PARA UTILIZAR EL INHIBIDOR DE NHE-1 Y COMPOSICIONES FARMACEUTICAS QUE CONTIENEN EL INHIBIDOR DE NHE-1. EL INHIBIDOR DE NHE-1 ES UTIL PARA LA REDUCCION DE LAS LESIONES TISULARES RESULTANTES DE LA ISQUEMIA DE LOS TEJIDOS.
SV2001000418A 2000-04-28 2001-04-27 Inhibidor del intercambiador de socio-hidrogeno de tipo 1 ref. pc1086aado/bb SV2002000418A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
SV2002000418A true SV2002000418A (es) 2002-07-03

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000418A SV2002000418A (es) 2000-04-28 2001-04-27 Inhibidor del intercambiador de socio-hidrogeno de tipo 1 ref. pc1086aado/bb

Country Status (40)

Country Link
EP (1) EP1276737A1 (es)
JP (1) JP2003531900A (es)
KR (1) KR20020093079A (es)
CN (1) CN1225466C (es)
AP (1) AP2002002651A0 (es)
AR (1) AR028375A1 (es)
AU (1) AU2001235896A1 (es)
BG (1) BG107139A (es)
BR (1) BR0110268A (es)
CA (1) CA2407535A1 (es)
CO (1) CO5221125A1 (es)
CR (1) CR6797A (es)
CZ (1) CZ20023408A3 (es)
DZ (1) DZ3310A1 (es)
EA (1) EA004882B1 (es)
EE (1) EE200200615A (es)
GT (1) GT200100064A (es)
HN (1) HN2001000042A (es)
HR (1) HRP20020851A2 (es)
HU (1) HUP0300651A2 (es)
IL (1) IL152075A0 (es)
IS (2) IS6567A (es)
MA (1) MA26897A1 (es)
MX (1) MXPA02010600A (es)
MY (1) MY133842A (es)
NO (1) NO20025132L (es)
NZ (1) NZ521348A (es)
OA (1) OA12256A (es)
PA (1) PA8513301A1 (es)
PE (1) PE20011270A1 (es)
PL (1) PL357765A1 (es)
SK (1) SK14872002A3 (es)
SV (1) SV2002000418A (es)
TN (1) TNSN01065A1 (es)
TR (1) TR200202439T2 (es)
UA (1) UA73348C2 (es)
UY (1) UY26680A1 (es)
WO (1) WO2001083470A1 (es)
YU (1) YU79602A (es)
ZA (1) ZA200208605B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004518686A (ja) * 2001-01-31 2004-06-24 ファイザー・プロダクツ・インク ナトリウム−水素交換輸送体１型阻害剤のエタノラート
EP1456181A1 (en) * 2001-12-19 2004-09-15 Pfizer Products Inc. Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
WO2003092694A1 (en) * 2002-05-02 2003-11-13 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
MXPA05008612A (es) * 2003-02-14 2005-12-05 Smithkline Beecham Corp Compuestos novedosos.
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1289326A (zh) * 1998-02-27 2001-03-28 辉瑞产品公司 用于治疗局部缺血的n－[(取代的五元二氮杂或三氮杂二不饱和环)羰基]胍衍生物

Also Published As

Publication number Publication date
CZ20023408A3 (cs) 2004-01-14
EA200201023A1 (ru) 2003-02-27
HUP0300651A2 (hu) 2003-07-28
PA8513301A1 (es) 2003-09-05
HRP20020851A2 (en) 2005-02-28
IS6588A (is) 2002-10-21
KR20020093079A (ko) 2002-12-12
UA73348C2 (en) 2005-07-15
AU2001235896A1 (en) 2001-11-12
MXPA02010600A (es) 2003-03-10
EA004882B1 (ru) 2004-08-26
IL152075A0 (en) 2003-05-29
OA12256A (en) 2003-11-06
AR028375A1 (es) 2003-05-07
TR200202439T2 (tr) 2003-02-21
HN2001000042A (es) 2001-07-09
UY26680A1 (es) 2001-12-28
WO2001083470A1 (en) 2001-11-08
BR0110268A (pt) 2003-12-30
CA2407535A1 (en) 2001-11-08
IS6567A (is) 2002-09-24
EP1276737A1 (en) 2003-01-22
MY133842A (en) 2007-11-30
PE20011270A1 (es) 2001-12-12
ZA200208605B (en) 2003-10-24
GT200100064A (es) 2002-03-22
CN1225466C (zh) 2005-11-02
DZ3310A1 (fr) 2001-11-07
CR6797A (es) 2004-05-17
NZ521348A (en) 2004-09-24
PL357765A1 (en) 2004-07-26
TNSN01065A1 (fr) 2005-11-10
NO20025132L (no) 2002-12-12
CO5221125A1 (es) 2002-11-28
JP2003531900A (ja) 2003-10-28
EE200200615A (et) 2004-04-15
SK14872002A3 (sk) 2004-03-02
MA26897A1 (fr) 2004-12-20
YU79602A (en) 2006-05-25
NO20025132D0 (no) 2002-10-25
CN1426404A (zh) 2003-06-25
BG107139A (bg) 2003-07-31
AP2002002651A0 (en) 2002-12-31

Similar Documents

Publication Publication Date Title
GT199900022A (es) Compuestos para el tratamiento de la isquemia
ES2195970T3 (es) L-ribavirina y usos de la misma.
AR019503A1 (es) Utilizacion de derivados sustituidos en 3 del estilbeno como agentes activos desodorantes en las composiciones cosmeticas
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
BR9913745A (pt) Cetonas de piridina úteis como herbicidas
BR0317822A (pt) Composição fluoroquìmica
ES2145638T3 (es) Nuevos compuestos azoicos, utilizacion para tincion, composiciones que los contienen y procedimientos de tincion.
BR0211390A (pt) Tratamento de infecções da unha com no
ES2193508T3 (es) Ftalizinonas.
SV2002000520A (es) Derivados de pirazol ref. pcs10927aajr/bb
BR9900320A (pt) Composição antimicrobiana
BR0215405A (pt) Composições e processos de uso de collajolie
SV2004001485A (es) Composicion de ziprasidona y controles sinteticos ref. pc23201
ECSP055747A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
ES2146552B1 (es) Peptidos inhibidores de tgf/31
NO996068L (no) Piperazinderivater og deres anvendelse som anti- inflammatoriske midler
BR9811948A (pt) Secretores de hormÈnio do crescimento
AR016981A2 (es) Polipeptidos sinteticos
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
AR015945A1 (es) Composiciones de spray para el cabello autofobicas
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
SV2002000418A (es) Inhibidor del intercambiador de socio-hidrogeno de tipo 1 ref. pc1086aado/bb
SE9801494D0 (sv) Novel use

Legal Events

Date Code Title Description
FD Lapse